期刊文献+

MIF和子痫前期炎症反应机制的关系 被引量:9

Study of the correlation with macrophage migration inhibition factor and the inflammation in preeclampsia
下载PDF
导出
摘要 目的研究子痫前期胎盘组织炎症反应情况及巨噬细胞移动抑制因子(MIF)的表达,探讨MIF在子痫前期炎症反应中的作用。方法选取住院分娩的子痫前期孕产妇53例,其中轻度子痫前期孕产妇25例(轻度子痫前期组),重度子痫前期孕产妇28例(重度子痫前期组)。另选取同期正常妊娠晚期孕产妇30例为对照组。采用逆转录(RT)PCR技术检测三组孕产妇胎盘组织中MIFmRNA的表达;采用免疫比浊法检测三组孕产妇血浆中CRP水平;采用ELISA方法检测三组孕产妇血浆中(TNF-α)、IL-6浓度。并对轻度及重度子痫前期组孕产妇血浆中CRP水平与胎盘组织中MIFmRNA表达的相关性进行分析。结果①三组孕产妇胎盘组织中均有MIF的表达,轻度子痫前期组孕产妇胎盘组织中MIFmRNA的水平为(0.84±0.13),重度子痫前期组为(1.05±0.11),两组比较,差异有统计学意义(P<0.01)。对照组孕产妇胎盘组织中MIFmRNA为(0.70±0.12),明显低于轻度及重度子痫前期组,差异均有统计学意义(P<0.01);②轻度子痫前期组孕产妇血浆CRP、(TNF-α)、IL-6浓度分别为(14.99±6.85)mg/L、(14.76±3.67)pg/ml、(24.68±10.13)pg/L,重度子痫前期组孕产妇血浆CRP、(TNF)、IL-6浓度分别为(21.16±8.89)mg/L、(19.66±6.13)pg/ml、(30.91±14.34)pg/L,差异有统计学意义(P<0.01);对照组孕产妇血浆CRP、(TNF)、IL-6浓度分别为(4.71±1.76)mg/L、(9.94±2.53)pg/ml、(14.14±5.06)pg/L,明显低于轻度及重度子痫前期组,差异有统计学意义(P<0.01);③轻度及重度子痫前期组孕产妇血浆中CRP水平与胎盘组织中MIFmRNA表达水平呈正相关(r=0.67,P<0.01)。结论子痫前期患者胎盘组织中的MIF的过度表达,可上调血浆中炎性标志物CRP的水平,引起血管内皮损伤,从而参与子痫前期的发病。 Objective To investigate the role of macrophage migration inhibition factor(MIF) and inflammation in placenta of preeclampsia.Methods 53 women were recruited,including 25 women with mild preeclampsia(MPE group) and 28 women with severe preeclampsia(SPE group).Another 30 healthy pregnant women were taken as control group. Semiquantitative RT-PCR was applied to detect the expression of MIF mRNA;The concentrations of C-reactive protein(CRP) in plasma were tested by immunoturbidimetry and the concentration of tumor necrosis factor-alpha(TNF-α )and interleukin-6(IL-6) were measured by enzyme linked immunosorbent assay (ELISA). The relationship between the level of CRP in plasma and MIF mRNA in placenta was analyzed in the MPE and SPE groups.Results ① MIF were expressed in the placenta of all pregnant women in the 3 groups. The level of MIF mRNA in the MPE group(0.84±0.13) and SPE group(1.05±0.11) was significantly higher than that in control group(0.70±0.12)(P0.01),and statistical significance was also found between the MPE and SPE group (P0.01).② The plasma level of CRP,(TNF-α ) and IL-6 in MPE and SPE group were significantly higher than that in control group[(14.99±6.85) mg/L,(14.76±3.67) pg/ml,(24.68±10.13) pg/L and (21.16±8.89) mg/L,(19.66±6.13) pg/ml,(30.91±14.34) pg/L vs (4.71±1.76) mg/L,(9.94±2.53) pg/ml,(14.14±5.06) pg/L (P0.01)],and significant difference was also found between the MPE and SPE group(P0.01).③ In the two preeclampsia groups, the plasma concentration of CRP was positively correlated- with the expression of MIFmRNA(r=0.67,P0.01) in placenta.Conclusion Over expression of MIF in the placenta may up-regulate the CRP level in plasma, resulting in systermic inflammatory reaction and vascular endothelium damage which may be involved in the pathogenesis of preeclampsia.
出处 《中国妇产科临床杂志》 2012年第3期179-182,共4页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 巨噬细胞移动抑制因子 子痫前期 C反应蛋白 炎症 Macrophage migration inhibition factor(MIF) preeclampsia C-reactive protein inflammation
  • 相关文献

参考文献12

  • 1林其德.对子痫前期的新认识[J].中华妇产科杂志,2009,44(2):81-83. 被引量:19
  • 2Vigan6 P, Cintorino M, Schatz F, et al. The role of macro- phage migration inhibitory factor in maintaining the immune privilege at the fetal - maternal interface. Semin Immuno- pathol, 2007, 29.. 135-150.
  • 3乐杰,谢幸,林仲秋,等.妇产科学.7版.北京:人民卫生出版社,2009:100.
  • 4Todros T, Bontempo S, Piccoli E, et aL Increased levels of mac- rophage migration inhibitory factor (MIF) in preeclampsia. Eur J Obstet Gynecol Reprod Biol, 2005, 123: 162- 166.
  • 5Hung TH, Charnock-Jones DS, Skepper JN, et al. Secre- tion of tumor necrosis factor - alpha from human placental tissues induced by hypoxia - reoxygenation cause endothelial cell activation in vitro., a potiential mediatior of the inflam- matory response in preeclampsia. Am J Pathol, 2004, 164: 1049 - 1061.
  • 6Lue H, Kleemann R, Calandra T, et al. Macrophage migra- tion inhibitory factor (MIF) : mechanisms of action and role in disease. Microbes Infect, 2002, 4: 449-460.
  • 7Santos LL, Morand EF. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis. Clin Chim Acta, 2009, 399:1-7.
  • 8Arcuri F, Buchwalder L, Toti P, et al. Differential regula- tion of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal - maternal interface. Biol Reprod, 2007, 76: 433 -439.
  • 9Ietta F, Todros T, Piccoli E, et al. Macrophage migration inhibitory factor in human pregnancy and labor. Am J Reprod Immunol, 2002, 48.. 404-409.
  • 10Ietta F, Wu Y, Romagnoli R, et al. Oxygen regulation of macrophage migration inhibitory factor in human placenta. Am J Physiol Endocrinol Metab, 2007, 292:272 - 280.

二级参考文献6

  • 1Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol,2007 ,76 :61- 67.
  • 2Sibai BM. Intergenerational factors : missing link for preeclampsia, fetal growth restriction, and cardiovascular disease? Hypertension, 2008,51:993-994.
  • 3Rustveld LO, Kelsey SF, Sharma R. Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies. Matern Child Health J,2008,12:223-242.
  • 4Laivuori H. Genetic aspects of preeclampsia. Front Biosci, 2007, 12:2372-2382.
  • 5Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy : an inflammatory view. Trends Immunol,2006,27 : 399- 404.
  • 6Knight M, Redman CW, Linton EA, et al. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol, 1998, 105:632- 640.

共引文献25

同被引文献73

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部